AI assistant
Sending…
Minerva Neurosciences, Inc. — Director's Dealing 2020
Oct 14, 2020
35086_dirs_2020-10-14_70f43d58-08df-4f45-b23b-5e9c711db548.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2020-10-13
Reporting Person: Race Geoff (EVP, CFO & CBO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-10-13 | Employee Stock Option (right to buy) | $3.50 | A | 140000 | Acquired | 2030-10-12 | Common Stock (140000) | Direct |
Footnotes
F1: One-third of this option vests on December 31, 2021 and the balance vests on December 31, 2022.
More from Minerva Neurosciences, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Capital/Financing Update
2026
May 27
Share Issue/Capital Change
2026
May 27
Interim / Quarterly Report
2026
May 5
Earnings Release
2026
May 5
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 6
Regulatory Filings
2026
Mar 20
Major Shareholding Notification
2026
Feb 17